Pre-clinical Studies

Pillar objectives Pillar 2 is dedicated to pre-clinical assessment of vaccine and antibody prototypes, including animal models (WP7), non-animal models (WP8) and immunomonitoring and immune profiling (WP9). Through a concerted effort by EVH partners, Pillar 2 aims to conceive and elaborate robust standardised protocols for pre-clinical analyses of vaccine and antibody candidates. WP7 Pre-clinical anima [...]